Supernus Pharmaceuticals, Inc.
US ˙ NasdaqGM ˙ US8684591089

Introduction

This page provides a comprehensive analysis of the known insider trading history of Bhatt Padmanabh P.. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

Companies with Reported Insider Positions

The SEC filings indicate Bhatt Padmanabh P. has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
US:SUPN / Supernus Pharmaceuticals, Inc. Sr. VP of IP, CSO 13,718
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by Bhatt Padmanabh P.. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Purchases SUPN / Supernus Pharmaceuticals, Inc. - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in SUPN / Supernus Pharmaceuticals, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

SUPN / Supernus Pharmaceuticals, Inc. Insider Trades
Insider Sales SUPN / Supernus Pharmaceuticals, Inc. - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in SUPN / Supernus Pharmaceuticals, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
2025-02-04 SUPN Bhatt Padmanabh P. 9,477 39.7000 9,477 39.7000 376,237 76 30.2900 -89,178 -23.70
2025-01-28 SUPN Bhatt Padmanabh P. 700 39.6200 700 39.6200 27,734
2025-01-27 SUPN Bhatt Padmanabh P. 2,573 39.6200 2,573 39.6200 101,942
2024-12-03 SUPN Bhatt Padmanabh P. 8,750 36.6800 8,750 36.6800 320,950
2024-12-03 SUPN Bhatt Padmanabh P. 12,745 36.6800 12,745 36.6800 467,487
2018-06-29 SUPN Bhatt Padmanabh P. 4,393 59.9028 4,393 59.9028 263,153

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

SUPN / Supernus Pharmaceuticals, Inc. Insider Trades
Insider Trading History

This table shows the complete list of insider trades made by Bhatt Padmanabh P. as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change
Share
Price
Tran
Value
Remaining
Value
2025-08-27 2025-08-25 4 SUPN SUPERNUS PHARMACEUTICALS, INC.
Common Stock
F - Taxes -581 13,718 -4.06 41.46 -24,088 568,748
2025-08-27 2025-08-25 4 SUPN SUPERNUS PHARMACEUTICALS, INC.
Common Stock
M - Exercise 1,250 14,299 9.58
2025-03-05 2025-03-05 4 SUPN SUPERNUS PHARMACEUTICALS, INC.
Common Stock
F - Taxes -575 12,704 -4.33 33.05 -19,004 419,867
2025-03-05 2025-03-05 4 SUPN SUPERNUS PHARMACEUTICALS, INC.
Common Stock
F - Taxes -575 12,704 -4.33 33.05 -19,004 419,867
2025-03-05 2025-03-05 4 SUPN SUPERNUS PHARMACEUTICALS, INC.
Common Stock
F - Taxes -335 13,854 -2.36 33.05 -11,072 457,875
2025-02-24 2025-02-23 4 SUPN SUPERNUS PHARMACEUTICALS, INC.
Common Stock
A - Award 1,250 14,189 9.66
2025-02-24 2025-02-22 4 SUPN SUPERNUS PHARMACEUTICALS, INC.
Common Stock
A - Award 1,250 12,939 10.69
2025-02-24 2025-02-22 4 SUPN SUPERNUS PHARMACEUTICALS, INC.
Common Stock
A - Award 750 11,689 6.86
2025-02-24 2025-02-21 4 SUPN SUPERNUS PHARMACEUTICALS, INC.
Common Stock
F - Taxes -860 10,939 -7.29 39.15 -33,669 428,262
2025-02-24 2025-02-21 4 SUPN SUPERNUS PHARMACEUTICALS, INC.
Common Stock
M - Exercise 1,650 11,799 16.26
2025-02-05 2025-02-04 4 SUPN SUPERNUS PHARMACEUTICALS, INC.
Common Stock
S - Sale -9,477 10,149 -48.29 39.70 -376,237 402,915
2025-02-05 2025-02-04 4 SUPN SUPERNUS PHARMACEUTICALS, INC.
Common Stock
M - Exercise 9,477 19,626 93.38 29.61 280,614 581,126
2025-01-29 2025-01-28 4 SUPN SUPERNUS PHARMACEUTICALS, INC.
Common Stock
S - Sale -700 10,149 -6.45 39.62 -27,734 402,103
2025-01-29 2025-01-28 4 SUPN SUPERNUS PHARMACEUTICALS, INC.
Common Stock
M - Exercise 700 10,849 6.90 29.61 20,727 321,239
2025-01-29 2025-01-27 4 SUPN SUPERNUS PHARMACEUTICALS, INC.
Common Stock
S - Sale -2,573 10,149 -20.22 39.62 -101,942 402,103
2025-01-29 2025-01-27 4 SUPN SUPERNUS PHARMACEUTICALS, INC.
Common Stock
M - Exercise 2,573 12,722 25.35 29.61 76,187 376,698
2024-12-04 2024-12-03 4 SUPN SUPERNUS PHARMACEUTICALS, INC.
Common Stock
S - Sale -12,745 9,679 -56.84 36.68 -467,487 355,026
2024-12-04 2024-12-03 4 SUPN SUPERNUS PHARMACEUTICALS, INC.
Common Stock
M - Exercise 12,745 22,424 131.68 25.30 322,448 567,327
2024-12-04 2024-12-03 4 SUPN SUPERNUS PHARMACEUTICALS, INC.
Common Stock
S - Sale -8,750 9,679 -47.48 36.68 -320,950 355,026
2024-12-04 2024-12-03 4 SUPN SUPERNUS PHARMACEUTICALS, INC.
Common Stock
M - Exercise 8,750 18,429 90.40 23.99 209,912 442,112
2024-08-20 2024-08-20 4 SUPN SUPERNUS PHARMACEUTICALS, INC.
Common Stock
F - Taxes -572 9,679 -5.58 29.57 -16,914 286,208
2024-08-20 2024-08-20 4 SUPN SUPERNUS PHARMACEUTICALS, INC.
Common Stock
M - Exercise 1,250 10,251 13.89
2024-03-25 2024-03-21 4 SUPN SUPERNUS PHARMACEUTICALS, INC.
Common Stock
S - Sale X -14,491 8,570 -62.84 35.31 -511,677 302,607
2024-03-25 2024-03-21 4 SUPN SUPERNUS PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 14,491 23,061 169.09 25.30 366,622 583,443
2024-03-22 2024-03-20 4 SUPN SUPERNUS PHARMACEUTICALS, INC.
Common Stock
S - Sale X -400 8,570 -4.46 35.31 -14,124 302,607
2024-03-22 2024-03-20 4 SUPN SUPERNUS PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 400 8,970 4.67 25.30 10,120 226,941
2024-03-21 2024-03-19 4 SUPN SUPERNUS PHARMACEUTICALS, INC.
Common Stock
S - Sale X -12,364 8,570 -59.06 35.31 -436,573 302,607
2024-03-21 2024-03-19 4 SUPN SUPERNUS PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 12,364 20,934 144.27 25.30 312,809 529,630
2024-03-15 2024-03-13 4 SUPN SUPERNUS PHARMACEUTICALS, INC.
Common Stock
S - Sale X -36,116 8,570 -80.82 33.48 -1,209,164 286,924
2024-03-15 2024-03-13 4 SUPN SUPERNUS PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 36,116 44,686 421.42 12.98 468,786 580,024
2024-03-15 2024-03-13 4 SUPN SUPERNUS PHARMACEUTICALS, INC.
Common Stock
S - Sale X -26,250 8,570 -75.39 34.10 -895,125 292,237
2024-03-15 2024-03-13 4 SUPN SUPERNUS PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 26,250 34,820 306.30 23.99 629,738 835,332
2024-03-14 2024-03-12 4 SUPN SUPERNUS PHARMACEUTICALS, INC.
Common Stock
S - Sale X -3,884 8,570 -31.19 32.99 -128,133 282,724
2024-03-14 2024-03-12 4 SUPN SUPERNUS PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 3,884 12,454 45.32 12.98 50,414 161,653
2024-02-28 2024-02-26 4 SUPN SUPERNUS PHARMACEUTICALS, INC.
Common Stock
S - Sale X -5,000 8,570 -36.85 30.21 -151,050 258,900
2024-02-28 2024-02-26 4 SUPN SUPERNUS PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 5,000 13,570 58.34 9.13 45,650 123,894
2024-02-27 2024-02-23 4 SUPN SUPERNUS PHARMACEUTICALS, INC.
Common Stock
F - Taxes -638 8,570 -6.93 29.06 -18,540 249,044
2024-02-27 2024-02-23 4 SUPN SUPERNUS PHARMACEUTICALS, INC.
Common Stock
A - Award 1,250 9,208 15.71
2024-02-26 2024-02-22 4 SUPN SUPERNUS PHARMACEUTICALS, INC.
Common Stock
F - Taxes -372 7,958 -4.47 27.94 -10,394 222,347
2024-02-26 2024-02-22 4 SUPN SUPERNUS PHARMACEUTICALS, INC.
Common Stock
A - Award 750 8,330 9.89
2023-09-07 2023-09-07 4 SUPN SUPERNUS PHARMACEUTICALS, INC.
Common Stock
F - Taxes -1,182 7,165 -14.16 32.10 -37,942 229,996
2023-09-07 2023-09-07 4 SUPN SUPERNUS PHARMACEUTICALS, INC.
Common Stock
M - Exercise 2,500 8,347 42.76
2023-05-12 2023-05-11 4 SUPN SUPERNUS PHARMACEUTICALS, INC.
Common Stock
M - Exercise 750 5,497 15.80
2023-04-12 2023-04-11 4 SUPN SUPERNUS PHARMACEUTICALS, INC.
Common Stock
A - Award 1,500 4,747 46.20
2023-02-24 2023-02-22 4 SUPN SUPERNUS PHARMACEUTICALS, INC.
Common Stock
A - Award 750 3,247 30.04
2023-01-19 2023-01-17 4 SUPN SUPERNUS PHARMACEUTICALS, INC.
Common Stock
S - Sale X -4,826 1,644 -74.59 39.92 -192,638 65,623
2023-01-19 2023-01-17 4 SUPN SUPERNUS PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 4,826 6,470 293.55 9.13 44,061 59,071
2023-01-09 2023-01-06 4 SUPN SUPERNUS PHARMACEUTICALS, INC.
Common Stock
S - Sale X -174 1,644 -9.57 39.90 -6,943 65,596
2023-01-09 2023-01-06 4 SUPN SUPERNUS PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 174 1,818 10.58 9.13 1,589 16,598
2022-12-02 2022-12-01 4 SUPN SUPERNUS PHARMACEUTICALS, INC.
Common Stock
S - Sale X -5,000 1,644 -75.26 37.48 -187,416 61,622
2022-12-02 2022-12-01 4 SUPN SUPERNUS PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 5,000 6,644 304.14 9.13 45,650 60,660
2022-11-15 2022-11-11 4 SUPN SUPERNUS PHARMACEUTICALS, INC.
Common Stock
S - Sale X -6,800 1,644 -80.53 34.95 -237,655 57,457
2022-11-15 2022-11-11 4 SUPN SUPERNUS PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 6,800 8,444 413.63 9.24 62,832 78,023
2022-11-14 2022-11-09 4 SUPN SUPERNUS PHARMACEUTICALS, INC.
Common Stock
S - Sale X -700 1,644 -29.86 34.97 -24,480 57,493
2022-11-14 2022-11-09 4 SUPN SUPERNUS PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 700 2,344 42.58 9.24 6,468 21,659
2022-08-05 2022-07-15 4 SUPN SUPERNUS PHARMACEUTICALS, INC.
Common Stock
A - Award 750 1,644 83.89
2022-02-25 2022-02-22 4/A SUPN SUPERNUS PHARMACEUTICALS, INC.
Restricted Stock Units
A - Award 3,000 3,000
2022-02-25 2022-02-22 4/A SUPN SUPERNUS PHARMACEUTICALS, INC.
Employee Stock Option (Right to Buy)
A - Award 18,000 18,000
2022-02-24 2022-02-22 4 SUPN SUPERNUS PHARMACEUTICALS, INC.
Restricted Stock Units
A - Award 3,000 3,000
2022-02-24 2022-02-22 4 SUPN SUPERNUS PHARMACEUTICALS, INC.
Employee Stock Option (Right to Buy)
A - Award 18,000 18,000
2021-02-23 2021-02-19 4 SUPN SUPERNUS PHARMACEUTICALS, INC.
Employee Stock Option (Right to Buy)
A - Award 17,000 17,000
2020-02-25 2020-02-21 4 SUPN SUPERNUS PHARMACEUTICALS, INC.
Employee Stock Option (Right to Buy)
A - Award 35,000 35,000
2019-02-26 2019-02-22 4 SUPN SUPERNUS PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
A - Award 35,000 35,000
2018-06-29 2018-06-29 4 SUPN SUPERNUS PHARMACEUTICALS INC
Common Stock
S - Sale -4,393 0 -100.00 59.90 -263,153
2018-06-29 2018-06-28 4 SUPN SUPERNUS PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise X -295 15,000 -1.93
2018-06-29 2018-06-28 4 SUPN SUPERNUS PHARMACEUTICALS INC
Common Stock
S - Sale X -3,402 4,393 -43.64 59.94 -203,899 263,295
2018-06-29 2018-06-28 4 SUPN SUPERNUS PHARMACEUTICALS INC
Common Stock
M - Exercise X 295 7,795 3.93 9.13 2,693 71,168
2018-06-22 2018-06-21 4 SUPN SUPERNUS PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise X -7,205 15,295 -32.02
2018-06-22 2018-06-21 4 SUPN SUPERNUS PHARMACEUTICALS INC
Common Stock
S - Sale X -7,205 7,500 -49.00 60.00 -432,323 450,024
2018-06-22 2018-06-21 4 SUPN SUPERNUS PHARMACEUTICALS INC
Common Stock
M - Exercise X 7,205 14,705 96.07 9.13 65,782 134,257
2018-05-16 2018-05-15 4 SUPN SUPERNUS PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise X -7,500 22,500 -25.00
2018-05-16 2018-05-15 4 SUPN SUPERNUS PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise X -368 7,500 -4.68
2018-05-16 2018-05-15 4 SUPN SUPERNUS PHARMACEUTICALS INC
Common Stock
S - Sale X -7,500 7,500 -50.00 57.93 -434,442 434,442
2018-05-16 2018-05-15 4 SUPN SUPERNUS PHARMACEUTICALS INC
Common Stock
M - Exercise X 7,500 15,000 100.00 9.13 68,475 136,950
2018-05-16 2018-05-15 4 SUPN SUPERNUS PHARMACEUTICALS INC
Common Stock
S - Sale X -368 7,500 -4.68 57.93 -21,317 434,442
2018-05-16 2018-05-15 4 SUPN SUPERNUS PHARMACEUTICALS INC
Common Stock
M - Exercise X 368 7,868 4.91 9.24 3,400 72,700
2018-05-14 2018-05-11 4 SUPN SUPERNUS PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise X -10,882 7,868 -58.04
2018-05-14 2018-05-11 4 SUPN SUPERNUS PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise X -11,250 18,750 -37.50
2018-05-14 2018-05-11 4 SUPN SUPERNUS PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise X -20,000 0 -100.00
2018-05-14 2018-05-11 4 SUPN SUPERNUS PHARMACEUTICALS INC
Common Stock
S - Sale X -10,882 7,500 -59.20 57.90 -630,068 434,250
2018-05-14 2018-05-11 4 SUPN SUPERNUS PHARMACEUTICALS INC
Common Stock
M - Exercise X 10,882 18,382 145.09 9.24 100,550 169,850
2018-05-14 2018-05-11 4 SUPN SUPERNUS PHARMACEUTICALS INC
Common Stock
S - Sale X -16,250 7,500 -68.42 55.23 -897,543 414,250
2018-05-14 2018-05-11 4 SUPN SUPERNUS PHARMACEUTICALS INC
Common Stock
M - Exercise X 11,250 23,750 90.00 9.24 103,950 219,450
2018-05-14 2018-05-11 4 SUPN SUPERNUS PHARMACEUTICALS INC
Common Stock
S - Sale X -20,000 12,500 -61.54 52.03 -1,040,558 650,349
2018-05-14 2018-05-11 4 SUPN SUPERNUS PHARMACEUTICALS INC
Common Stock
M - Exercise X 20,000 32,500 160.00 7.90 158,000 256,750
2018-05-14 2018-05-10 4 SUPN SUPERNUS PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise X -20,000 20,000 -50.00
2018-05-14 2018-05-10 4 SUPN SUPERNUS PHARMACEUTICALS INC
Common Stock
S - Sale X -20,000 12,500 -61.54 49.88 -997,544 623,465
2018-05-14 2018-05-10 4 SUPN SUPERNUS PHARMACEUTICALS INC
Common Stock
M - Exercise X 20,000 32,500 160.00 7.90 158,000 256,750
2018-02-16 2018-02-14 4 SUPN SUPERNUS PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
A - Award 30,000 30,000
2018-01-22 2018-01-22 4 SUPN SUPERNUS PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise X -20,000 40,000 -33.33
2018-01-22 2018-01-22 4 SUPN SUPERNUS PHARMACEUTICALS INC
Common Stock
S - Sale X -20,000 12,500 -61.54 48.04 -960,716 600,448
2018-01-22 2018-01-22 4 SUPN SUPERNUS PHARMACEUTICALS INC
Common Stock
M - Exercise X 20,000 32,500 160.00 7.90 158,000 256,750
2018-01-17 2018-01-17 4 SUPN SUPERNUS PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise X -20,000 60,000 -25.00
2018-01-17 2018-01-17 4 SUPN SUPERNUS PHARMACEUTICALS INC
Common Stock
S - Sale X -20,000 12,500 -61.54 44.98 -899,500 562,188
2018-01-17 2018-01-17 4 SUPN SUPERNUS PHARMACEUTICALS INC
Common Stock
M - Exercise X 20,000 32,500 160.00 7.90 158,000 256,750
2017-09-11 2017-09-08 4 SUPN SUPERNUS PHARMACEUTICALS INC
Common Stock
S - Sale X -5,000 12,500 -28.57 49.86 -249,302 623,256
2017-08-16 2017-08-16 4 SUPN SUPERNUS PHARMACEUTICALS INC
Common Stock
S - Sale X -3,709 17,500 -17.49 45.23 -167,755 791,509
2017-07-14 2017-07-12 4 SUPN SUPERNUS PHARMACEUTICALS INC
Common Stock
S - Sale X -3,735 21,209 -14.97 44.90 -167,702 952,284
2017-06-27 2017-06-23 4 SUPN SUPERNUS PHARMACEUTICALS INC
Common Stock
S - Sale X -2,556 24,944 -9.29 44.90 -114,774 1,120,083
2017-06-05 2017-06-02 4 SUPN SUPERNUS PHARMACEUTICALS INC
Common Stock
S - Sale X -10,000 27,500 -26.67 39.86 -398,558 1,096,034
2017-05-30 2017-05-26 4 SUPN SUPERNUS PHARMACEUTICALS INC
Common Stock
S - Sale X -2,500 37,500 -6.25 35.90 -89,758 1,346,362
2017-05-25 2017-05-25 4 SUPN SUPERNUS PHARMACEUTICALS INC
Common Stock
S - Sale X -3,887 40,000 -8.86 34.90 -135,656 1,396,000
2017-05-25 2017-05-24 4 SUPN SUPERNUS PHARMACEUTICALS INC
Common Stock
S - Sale X -1,613 43,887 -3.55 34.90 -56,294 1,531,656
2017-04-24 2017-04-24 4 SUPN SUPERNUS PHARMACEUTICALS INC
Common Stock
S - Sale X -11,806 45,500 -20.60 32.59 -384,762 1,482,863
2017-02-27 2017-02-24 4 SUPN SUPERNUS PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
A - Award 40,000 40,000
2016-04-12 2016-04-11 4 SUPN SUPERNUS PHARMACEUTICALS INC
Common Stock
S - Sale X -30,762 57,306 -34.93 16.49 -507,228 944,907
2016-03-03 2016-03-01 4 SUPN SUPERNUS PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
A - Award 40,000 40,000
2015-12-10 2015-12-09 4 SUPN SUPERNUS PHARMACEUTICALS INC
Common Stock
S - Sale X -4,685 88,068 -5.05 14.90 -69,806 1,312,213
2015-12-10 2015-12-08 4 SUPN SUPERNUS PHARMACEUTICALS INC
Common Stock
S - Sale X -9,553 92,753 -9.34 14.90 -142,341 1,382,029
2015-11-06 2015-11-04 4 SUPN SUPERNUS PHARMACEUTICALS INC
Common Stock
S - Sale X -5,000 102,306 -4.66 19.90 -99,500 2,035,889
2015-03-05 2015-03-03 4 SUPN SUPERNUS PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
A - Award 30,000 30,000
2015-01-16 2015-01-15 4 SUPN SUPERNUS PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -37,500 0 -100.00
2015-01-16 2015-01-15 4 SUPN SUPERNUS PHARMACEUTICALS INC
Common Stock
M - Exercise 37,500 107,306 53.72 2.56 96,000 274,703
2015-01-08 2015-01-05 4 SUPN SUPERNUS PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -2,500 0 -100.00
2015-01-08 2015-01-05 4 SUPN SUPERNUS PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -3,000 0 -100.00
2015-01-08 2015-01-05 4 SUPN SUPERNUS PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -12,500 0 -100.00
2015-01-08 2015-01-05 4 SUPN SUPERNUS PHARMACEUTICALS INC
Common Stock
M - Exercise 2,500 69,806 3.71 3.36 8,400 234,548
2015-01-08 2015-01-05 4 SUPN SUPERNUS PHARMACEUTICALS INC
Common Stock
M - Exercise 3,000 67,306 4.67 0.40 1,200 26,922
2015-01-08 2015-01-05 4 SUPN SUPERNUS PHARMACEUTICALS INC
Common Stock
M - Exercise 12,500 64,306 24.13 0.40 5,000 25,722
2014-01-23 2014-01-21 4 SUPN SUPERNUS PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
A - Award 30,000 30,000
2013-08-21 2013-08-19 4 SUPN SUPERNUS PHARMACEUTICALS INC
Common Stock
S - Sale X -2,285 51,806 -4.22 8.21 -18,760 425,327
2013-02-12 2013-02-08 4 SUPN SUPERNUS PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -25,000 12,500 -66.67
2013-02-12 2013-02-08 4 SUPN SUPERNUS PHARMACEUTICALS INC
Common Stock
M - Exercise 25,000 51,806 93.26 0.40 10,000 20,722
2013-02-07 2013-02-05 4 SUPN SUPERNUS PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
A - Award 80,000 80,000
2012-06-20 2012-06-18 4 SUPN SUPERNUS PHARMACEUTICALS INC
Employee Stock Option (right to buy)
M - Exercise -25,000 37,500 -40.00
2012-06-20 2012-06-18 4 SUPN SUPERNUS PHARMACEUTICALS INC
Common Stock
M - Exercise 25,000 25,000 0.40 10,000 10,000
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)